Results of crossover phase II component of randomized placebo-controlled trial evaluating oral THC/cannabis extract for refractory chemotherapy-induced nausea and vomiting (CINV).

Citation

• Grimison, P. S., Stockler, M. R., Kirby, A., Walsh, A., Lintzeris, N., Cheung, Y., . . . Della-Fiorentina, S. (2020). Results of crossover phase II component of randomized placebo-controlled trial evaluating oral THC/cannabis extract for refractory chemotherapy-induced nausea and vomiting (CINV).. Journal of Clinical Oncology, 38(15_suppl), 12008. doi:10.1200/jco.2020.38.15_suppl.12008

Digital Object Identifier (doi)

• 10.1200/jco.2020.38.15_suppl.12008

Web Of Science Accession Number

Start Page

• 12008

End Page

• 12008

Volume

• 38

Issue

• 15_suppl

Place Of Publication

Abstract

UOW Authors

•   Aghmesheh, Morteza (external author)

Publication Date

• 2020

Publisher

• American Society of Clinical Oncology (ASCO) 

Published In

• Journal of Clinical Oncology  Journal

Citation

• Grimison, P. S., Stockler, M. R., Kirby, A., Walsh, A., Lintzeris, N., Cheung, Y., . . . Della-Fiorentina, S. (2020). Results of crossover phase II component of randomized placebo-controlled trial evaluating oral THC/cannabis extract for refractory chemotherapy-induced nausea and vomiting (CINV).. Journal of Clinical Oncology, 38(15_suppl), 12008. doi:10.1200/jco.2020.38.15_suppl.12008

Digital Object Identifier (doi)

• 10.1200/jco.2020.38.15_suppl.12008

Web Of Science Accession Number

Start Page

• 12008

End Page

• 12008

Volume

• 38

Issue

• 15_suppl

Place Of Publication